Human Immunology Biosciences
HI-Bio was established on the premise that treatments for immune-mediated illnesses have the potential to provide patients with better outcomes.
$95M
Latest Funding
Series B
Latest Funding Stage
2024-01-04
Funding Date
47
Employees
United States
Location
San Francisco, California
City & State
Sales-Ready Summary
Hibio recently raised a $95M Series B and utilizes Vercel, Termly, and GoDaddy, suggesting they are scaling their platform and operations. Companies offering PaaS, cookie compliance, or hosting solutions should reach out to discuss potential vendor needs.
Key Contacts
Open Positions
View Careers PageSimilar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.